Skip To Content

Study ID: Immune Tolerance Network ITN058AI EXTEND trial

Title:

Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes

Description:
EXTEND
Location:
Sioux Falls Region
Principal Investigator:
Kurt Griffin, MD, PhD
Disease:
Stage:
Phase II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.